CVS progress reports - Winter/Spring 2011

Thursday 31st March

Speaker 1: Mairead Butler: Developing methods of imaging the microvasculature using contrast enhanced ultrasound Speaker 2: Gregorio Naredo : 19F Magnetic Resonance Spectroscopy as tool to asses 11β-HDS1 activity in-vivo in rats Chair: Patrick Hadoke

Thursday 24th March

Speaker 1: Jonathan Manning: Protein sequence, structure and function: case studies from bioinformatics

Speaker 2: Rita Upreti: Metabolic effects of 5 alpha reductase inhibition in humans

Chair: Scott Webster

Thursday 17th March

Speaker 1: Nichola Brydges: Developing an animal model of delirium

Speaker 2: Linda Mullins: Gene targeting in the rat

Chair: Megan Holmes

Thursday 10th March

Speaker 1: James Catterson: Drosophila melanogaster as a model of human heart function

Speaker 2: Nusrat Khan: Stem cells in Orthopaedics

Chair: Megan Holmes

Thursday 3rd March

Speaker 1: Melissa Cudmore: The regulation of sEndoglin by vascular protective factors

Speaker 2: Meng Cai: Endothelial Nitric Oxide Synthase and Heme Oxygenase regulate Angiogenesis via p21WAF1 in a diametrically opposed manner.

Chair: Nik Morton

Thursday 27th January

We have one speaker followed by (an internal) CVS discussion on changes to the CPR series agreed at the recent SSC meeting.

Speaker 1: Dawn Livingstone: "5alpha-Reductase 1: Tissue specific modulator of glucocorticoid action"

Chair: Nik Morton

followed by:

Session 2 (all CVS member open discussion): Nik Morton (chair): Proposed changes to the CPR format and remit.

Thursday 20th January

Speaker 1. Andrew McBride: “11b-HSD1 Drug Discovery - Assessing Compound Efficacy”

Speaker 2. Alison MacKinnon: “Role of galectin-3 (Mac-2) in atherosclerosis”.

Chair: Nik Morton.

Thursday 13th January

Speaker 1: Takeshi Fujisawa: The role of Angiopoietins in the context of the atherosclerosis

Speaker 2: Cristina Esteves: Transcriptional regulation of 11b-HSD1 - C/EBPb, pro-inflammatory cytokines and metabolism

Chair: Ruth Andrew